Pharmaceuticals

Clear Insights from User and Physician Feedback

Data is critical in assessing patient experiences with and physicians’ impressions of pharmaceutical products. And in an industry where risk is always high, Lumivero’s solutions go end-to-end and even empower pharmaceutical companies to organize sources and generating outlines that make a report half-done before you even start writing it.

Imperatives for Pharma: Clear-Eyed Views of Data and Risk

Hearing from consumers and their physicians about their experiences with pharmaceutical products are necessary for continuous development and improvement of products. But qualitative data is historically difficult to organize and analyze. Lumivero’s suite of comprehensive software solutions has changed that with tools to help identify patterns and trends in qualitative data - supporting research dependability while providing valuable reference data going forward. The pharmaceutical industry’s work is too important to rely on anything but the best tools to turn data into action.

Reliable Clinical Trials

Clinical trials involve high volumes of both qualitative and quantitative data. Lumivero software solutions support mixed-methods research by aligning with leading survey platforms and applying analytical tools to gather patterns and trends from interviews and focus groups to provide useful reference data. And with Lumivero’s tools, pharmaceutical companies can get help organizing sources and generating outlines that make a report half-done before you even start writing it.
Available Products:

Understand Consumer Experiences

People trust you to deliver the best possible care, and to do so you need a clear picture of the general sentiment and overall patient experience. Compile feedback and reviews, then compare them against quantitative metrics to understand what you need to do to help improve how your consumers view a visit to the hospital, or doctor’s office.
Available Products:

R&D Risk Analysis

So much capital is on the line with each commitment a pharmaceutical company makes to researching a new drug. Lumivero’s suite of products can show you the likelihood of staying within budget on these initiatives and can run simulations to show you the likely outcomes of different decisions you make along the way, so you will choose with clear insight about the possible results you will experience. With Lumivero, you can back up statistical research with insights from thematic analysis of qualitative data that articulates the importance of your work. Whether you’re testing new treatments, offering a teaching hospital program, or measuring patient outcomes, Lumivero helps you centralize, code, and visualize your data for program evaluations, drug acceptability trials, and systematic reviews.
Available Products:

FAQS

Everything You Need to Know 
to Elevate Your Research

How does Lumivero help those in pharmaceuticals create impact with their data?

Lumivero’s suite of comprehensive software solutions has tools to help identify patterns and trends in qualitative data - supporting research dependability while providing valuable reference data going forward. And in an industry where risk is always high - and where the nature of risk is constantly in flux - Lumivero’s solutions help pharmaceutical companies run simulations, envisioning possible outcomes to help drive better decision-making.

How does the pharmaceutical industry use qualitative data analysis?

Thematic analysis of qualitative data helps those in the pharmaceutical industry back up statistical research with insights and articulate the importance of their work.

How does Lumivero help those in the pharmaceutical industry develop risk evaluation and mitigation strategies (REMS)?

N/A

Featured Case Studies

Merck Uses @RISK for Value-at-Risk

The Director of Foreign Exchange at multinational pharmaceutical giant Merck uses @RISK to evaluate value-at-risk (VAR) for currency risks.]

UCSD Research uses Lumivero tools to Inform Public Health Policy

Researchers at the University of California San Diego School of Medicine used @RISK and PrecisionTree to create a more effective and nuanced screening program.

Using Lumivero tools to Shape the Future of Drug Development in Neurodegenerative Diseases

AC Immune SA, a biopharmaceutical company used @RISK and PrecisionTree, to assess the value of the company’s development candidates leading to overall enterprise value.
“Nothing in the real world is independent—all variables are closely dependent on each other. With @RISK, when I defined the distribution, I was able to put in the correlation between the variables, which got discounted in the outcome, and allowed me to see the real effect of each variable. It’s very powerful from that standpoint—it makes a real life example in situations where there’s just no way I could get data from 10,000 donors.”
Dr. Bekir Tanriover
Assistant Professor of Internal Medicine, University of Texas Southwestern Medical Center
“While many software tools can help solve complex decision problems, I have found Palisade’s DecisionTools Suite to be highly adaptable to the idiosyncratic drug development and selection problems I encounter in the Biopharmaceutical industry.”
Richard Bayney
Project and Portfolio Value Creation
“PrecisionTree allows us to set up dynamic decision trees linked to underlying cash flows to understand the risk/return at a specific point in time along the development timeline, additionally, it helps us weight a decision such as to partner or not partner a potential product candidate.”
Julian Snow
AVP of Financial Reporting, AC Immune SA

Impactful Results for Improved Health

Great research comes from deep insights based on a range of data. Take advantage of Lumivero’s range of integrations to easily import, organize and manage data from multiple sources.
get Started
magnifierarrow-right linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram